2010 News

The implantable bioartifical kidney is explained in this December 6, 2010, SmartPlanet video featuring Shuvo Roy, PhD, a faculty member in the UCSF Schools of Pharmacy and Medicine.
Shuvo Roy, PhD
Shuvo Roy, PhD, an engineer and research scientist, is leading a U.S. project to build the world’s first bioartifical kidney to treat end stage renal disease. The goal is to surgically implant this coffee-cup-sized device in a human patient within 5 to 7 years. The bioartificial kidney both filters toxins from the blood and performs many of the metabolic functions of the healthy kidney. And, the bioartificial kidney requires no batteries or external pumps.
Paul Ortiz de Montellano, PhD, is the newly appointed associate dean of research in the UCSF School of Pharmacy. The associate dean of research advises the UCSF School of Pharmacy dean and leaders on research trends, issues, and opportunities and represents the School's research agenda to the campus.
Kathy Giacomini, PhD, co-chair of the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine, will receive the 2010 Therapeutic Frontiers Lecture Award from the American College of Clinical Pharmacy on October 17, 2010, in Austin, Texas at ACCP's annual meeting.
UCSF, Harvard University, and Stanford University have been ranked as the top three world universities in the broad subject fields of clinical medicine and pharmacy in the 2010 Academic Ranking of World Universities (ARWU), which was released on August 15, 2010, by the Center for World-Class Universities of Shanghai Jiao Tong University.
A national research project is under way to develop an surgically implantable bioartificial kidney using the latest advances in science and technology with the goal of both improving the health and lives of patients with end stage renal disease and saving health care dollars.
Michael Fischbach, PhD
Michael Fischbach, PhD, is the recipient of a 2010 NIH Director's New Innovator Award from the National Institutes of Health. Fischbach is a faculty member in the Department of Bioengineering and Therapeutic Sciences, UCSF Schools of Pharmacy and Medicine.
Fresh UCSF Leadership: Desmond-Hellmann, Bluestone, Plotts, Harel, Moss, Hawgood, Featherstone; Leadership Transitions: Debas, Feachem, Dracup; UCSF Economic Impact Report; UCSF Operations and Budget Cuts: 3 campus work groups, 3 fiscal challenges, $28 million cut; UCSF Physical and Program Plans: Osher Center for Integrative Medicine, Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research; The School in Context; New and Departing Faculty Members: Shu, Brock, Dill; Faculty H
Kathy Giacomini, PhD, co-chair of the UCSF Department of Bioengineering and Therapeutic Sciences and an expert in the field of pharmacogenomics, is leading two research projects funded by two grants totaling $15.1 million over the next five years to expand research into how genes affect an individual's response to medication and to strengthen a global network of researchers
Shuvo Roy, PhD
The model for a surgically implantable bioartificial kidney the size of a coffee cup has been unveiled by the national project's lead researcher, Shuvo Roy, PhD, a member of the UCSF Department of Bioengineering and Therapeutic Sciences.
Michael Fischbach, PhD
Michael Fischbach, PhD, a faculty member in UCSF's Department of Bioengineering and Therapeutic Sciences, is one of two recipients of the 2010 Young Investigator Grant for Probiotics Research. The announcement was made August 2, 2010, by The Global Products Council, which funds the program to contribute to the advancement of probiotics and gastrointestinal microbiota research in the United States.
Genetic ancestry
Genetic ancestry can tell more about a person's potential lung function than the self-identified racial profile commonly used to determine normal lung function reference standards, according to the results of research led by UCSF and Northwestern University.
key women in science research and education at UCSF
Four members of the UCSF School of Pharmacy faculty have been named from among a list of 14 as key women in science research and education at UCSF. They are (pictured left-to-right):
Dr. Esteban González Burchard, MD, MPH
Asthma specialist and genetics researcher, Dr. Esteban G. Burchard, MD, MPH, joint faculty member in the UCSF Schools of Pharmacy and Medicine, discusses the differences in the incidence of asthma and response to asthma drugs among various subgroups within the larger Latino population. His goal is to find the underlying genetic reasons for these differences and to use this knowledge to improve asthma treatment. The report appeared April 27, 2010, on ABC 7 TV.
For his historic contributions to what is now known about the rate at which drugs are broken down and "cleared" from the body, Leslie Benet, PhD, was honored by the American Society for Clinical Pharmacology and Therapeutics (ASCPT) with the Oscar B. Hunter Memorial Award in Therapeutics.
Mary Anne Koda-Kimble, PharmD, dean of the UCSF School of Pharmacy, has been named by the American Association of Colleges of Pharmacy (AACP) as the 2010 recipient of the Robert K. Chalmers Distinguished Pharmacy Educator Award.
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, will receive the 2010 Remington Honor Medal from the American Pharmacists Association (APhA) on March 13, 2010, at APhA's annual meeting in Washington, DC
Research: 30th anniversary as the nation's top National Institutes of Health-funded pharmacy school, Lightwood, Mandell, Kortemme, Coutsias, Keiser, Shoichet, Irwin, Laggner, Hert, Thomas, Edwards, Voigt, Levskaya, Lim, Weiner, Craik, Darragh, Schneider, Farady, Lou, Marks, Phojanakong, Hann. Faculty honors and awards: Stebbins, Levens Lipton, Benet, Giacomini, Gazzaley, Yee, Hessol, Roy. Department of Bioengineering and Therapeutic Sciences inaugural forum.
symposium
In the first symposium held by the newly minted UCSF Department of Bioengineering and Therapeutic Sciences, researchers described progress in the fields of systems biology, pharmacogenomics, and bioengineering, and how scientists in these fields are working in concert to develop novel diagnostics and therapeutics to effectively and safely diagnose and treat disease.
Esteban G. Burchard, MD, MPH
Esteban G. Burchard, MD, MPH, a UCSF School of Pharmacy faculty member, explains the differences between race and ethnicity and the promise that greater genetic knowledge holds for addressing disease during a panel discussion on National Public Radio, Science Friday that aired January 15, 2010.